ES2088024T3 - Sistema de formulacion de lipidos. - Google Patents

Sistema de formulacion de lipidos.

Info

Publication number
ES2088024T3
ES2088024T3 ES91919389T ES91919389T ES2088024T3 ES 2088024 T3 ES2088024 T3 ES 2088024T3 ES 91919389 T ES91919389 T ES 91919389T ES 91919389 T ES91919389 T ES 91919389T ES 2088024 T3 ES2088024 T3 ES 2088024T3
Authority
ES
Spain
Prior art keywords
lipid
matrix
particle forming
lipid particle
forming matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919389T
Other languages
English (en)
Inventor
Bengt Herslof
Martin Nicklasson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Application granted granted Critical
Publication of ES2088024T3 publication Critical patent/ES2088024T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Fertilizers (AREA)

Abstract

LA INVENCION ESTA RELACIONADA CON UNA MATRIZ DE FORMACION DE PARTICULAS DE LIPIDOS, CARACTERIZADA EN TANTO QUE A PARTIR DE UN SISTEMA DEFINIDO DE, AL MENOS, DOS COMPONENTES LIPIDICOS SELECCIONADOS DE CLASES DE DISTINTA POLARIDAD, EN EL QUE, AL MENOS, UNO DE LOS COMPONENTES LIPIDICOS FORMA CAPAS DOBLES, SE FORMAN PARTICULAS DISCONTINUAS DE LIPIDOS DE FORMA ESPONTANEA CUANDO INTERACTUAN CON SISTEMAS ACUOSOS. PREFERIBLEMENTE, AL MENOS UNO DE LOS COMPONENTES LIPIDICOS ES ANFIFATICO Y POLAR Y UNO ES NO POLAR. ESTAS PARTICULAS DISCONTINUAS SE FORMAN ESPONTANEAMENTE A PARTIR DE LA MATRIZ SIN NINGUN TRATAMIENTO NI INICIACION QUIMICO/A NI FISICO/A. LA MATRIZ FORMADORA DE PARTICULAS LIPIDICAS PUEDE CONTENER MATERIALES BIOACTIVOS, SELECCIONADOS DEL GRUPO DE MEDICAMENTOS, HERBICIDAS, PESTICIDAS, FERTILIZANTES, INGREDIENTES O ADITIVOS ALIMENTARIOS O COSMETICOS. LA INVENCION TAMBIEN ESTA RELACIONADA CON UN PROCESO PARA LA PRODUCCION DE LA MATRIZ, EL USO DE LA MATRIZ FORMADORA DE PARTICULAS LIPIDICAS COMOSISTEMA PORTADOR PARA MATERIALES BIOACTIVOS Y COMPOSICIONES FARMACEUTICAS TALES COMO VEHICULOS ORALES, RECTALES, NASALES, VAGINALES, OCULARES O PARENTERALES, CREMAS, UNGUENTOS, CAPSULAS Y COMPRIMIDOS QUE CONTIENEN DICHA MATRIZ FORMADORA DE PARTICULAS LIPIDICAS Y UN MEDICAMENTO.
ES91919389T 1990-09-28 1991-09-24 Sistema de formulacion de lipidos. Expired - Lifetime ES2088024T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system

Publications (1)

Publication Number Publication Date
ES2088024T3 true ES2088024T3 (es) 1996-08-01

Family

ID=20380490

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91919389T Expired - Lifetime ES2088024T3 (es) 1990-09-28 1991-09-24 Sistema de formulacion de lipidos.

Country Status (15)

Country Link
EP (1) EP0514506B1 (es)
JP (1) JP2855594B2 (es)
AT (1) ATE137667T1 (es)
AU (1) AU645143B2 (es)
CA (1) CA2069760C (es)
DE (1) DE69119400T2 (es)
DK (1) DK0514506T3 (es)
ES (1) ES2088024T3 (es)
FI (1) FI107696B (es)
GR (1) GR3020674T3 (es)
IE (1) IE62194B1 (es)
NO (1) NO304729B1 (es)
PT (1) PT99113B (es)
SE (1) SE9003100D0 (es)
WO (1) WO1992005771A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
KR100220546B1 (ko) * 1994-02-04 1999-09-15 벵 헤르슬로프 호지성 담체 제제
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
SE9703691D0 (sv) 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
EP1140021B1 (en) 1998-12-23 2004-08-04 Idea Ag Improved formulation for topical non-invasive application in vivo
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
FR2868704B1 (fr) * 2004-04-07 2007-09-14 Ethypharm Sa Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires
MXPA06011871A (es) 2004-04-15 2007-10-08 Chiasma Inc Composiciones capaces de facilitar la penetracion a traves de una barrera biologica.
MX2007013421A (es) * 2005-04-28 2008-01-16 Galenica Technology Ab Formas de dosificacion farmaceutica que comprenden una fase lipida.
ATE544444T1 (de) * 2005-10-11 2012-02-15 Yissum Res Dev Co Zusammensetzungen für die nasale abgabe
WO2010032140A2 (en) 2008-09-17 2010-03-25 Chiasma Inc. Pharmaceutical compositions and related methods of delivery
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
AU2021444376A1 (en) * 2021-05-03 2023-11-16 Mcal Therapeutics Inc. Micronized lipids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT8219012A0 (it) * 1982-01-06 1982-01-06 Ausonia Farma Srl Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
ATE115403T1 (de) * 1987-01-27 1994-12-15 Vestar Inc Aus phospholipiden bestehende darreichungsform für wasserunlösliche wirksubstanzen.

Also Published As

Publication number Publication date
PT99113B (pt) 1999-02-26
FI922452A0 (fi) 1992-05-27
ATE137667T1 (de) 1996-05-15
IE62194B1 (en) 1994-12-28
CA2069760A1 (en) 1992-03-29
AU8710591A (en) 1992-04-28
NO304729B1 (no) 1999-02-08
SE9003100D0 (sv) 1990-09-28
AU645143B2 (en) 1994-01-06
NO922084L (no) 1992-05-26
FI922452A (fi) 1992-05-27
WO1992005771A1 (en) 1992-04-16
EP0514506B1 (en) 1996-05-08
EP0514506A1 (en) 1992-11-25
PT99113A (pt) 1992-08-31
DE69119400D1 (de) 1996-06-13
IE913246A1 (en) 1992-04-08
GR3020674T3 (en) 1996-10-31
JP2855594B2 (ja) 1999-02-10
DK0514506T3 (da) 1996-08-12
NO922084D0 (no) 1992-05-26
FI107696B (fi) 2001-09-28
JPH05503711A (ja) 1993-06-17
DE69119400T2 (de) 1996-12-05
CA2069760C (en) 1998-02-10

Similar Documents

Publication Publication Date Title
ES2088024T3 (es) Sistema de formulacion de lipidos.
DE3681755D1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
DK233080A (da) Overtraeksmiddel til foedevarer og medicinalvarer fremgangsmaade til fremstilling deraf samt produkter forsynet med et saadant overtraek
FR2778406B1 (fr) Derives d'alpha-cetoamides, procede pour leur preparation, preparations pharmaceutiques les contenant, et leur utilisation en tant que medicaments anti-viraux
IE54084B1 (en) Medicaments with a high degree of solubility and method for their production
DE68920394D1 (de) Heterozyklische Verbindungen und Arzneimittel, die die Wirkung von Antikrebsmitteln verstärken, welche diese als wirksame Bestandteile enthalten.
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
FR2334359A1 (fr) Derives de l'isoquinoleine, leur preparation et medicaments contenant ces substances
HUT70150A (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines, pharmaceutical compositions containing them and method for its preparation
KR900005990A (ko) 차전자(psyllium)-함유 생성물
ES2058988T3 (es) Preparacion de medicamentos para el tratamiento sistemico de peces ornamentales y utiles.
NO933323D0 (no) Naerings- og medikamentblandinger paa basis av kitosan for administrering til droevtyggere
JPS5225015A (en) Process for preparing fine granular drugs
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
FR2676648B1 (fr) Nouvelles compositions, leur procede de preparation et leurs applications comme substance active de medicament antigrippal ou antiviral.
JPS61178914A (ja) ヒト及び動物の耳への局所投与用不溶性薬剤
BE862053A (fr) Peptides contenant de la phenylglycine utiles comme medicaments, procede pour leur preparation et compositions pharmaceutiques en contenant
BE874154A (fr) Derives de l'eburnamonine, leur preparation et medicaments contenant ces substances
KR100486794B1 (ko) 다른 상 운반체 사이에서 하나 또는 그 이상의 활성인자를 이동시키는 방법
FR2690159B1 (fr) Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant.
Islam Biosensors Journal
TH13351A (th) สารประกอบ
KR960033455A (ko) 항암조성물
Papadakis et al. Potential anticancer compounds with structural relation to podophyllotoxin. Synthesis of 5-(4', 5', 6'-trimethoxyphenyl)-bis-lactone (3-hydroxymethyl-4-carboxy and 1-hydroxymethyl-6-carboxy)-3, 6-cyclohexadiene and related compounds
NL180479C (nl) Werkwijze voor de bereiding of vervaardiging van geneesmiddelen met ontstekingsremmende en corticoide activiteit, gevormde geneesmiddelen alsmede werkwijze voor de bereiding van 1,4-pregnadieenverbindingen, geschikt voor het gebruik als werkzame stof in deze geneesmiddelen.

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19931209

FG2A Definitive protection

Ref document number: 514506

Country of ref document: ES